Trinity Biotech PLC (TRIB)
1.58
+0.01
(+0.64%)
USD |
NASDAQ |
May 17, 16:00
1.57
-0.01
(-0.63%)
After-Hours: 20:00
Trinity Biotech Cash from Investing (Quarterly): -0.891M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.891M |
| September 30, 2023 | -0.886M |
| June 30, 2023 | 27.86M |
| March 31, 2023 | -1.329M |
| December 31, 2022 | -1.137M |
| September 30, 2022 | -1.324M |
| June 30, 2022 | -1.801M |
| March 31, 2022 | -1.715M |
| December 31, 2021 | -2.475M |
| September 30, 2021 | -1.959M |
| June 30, 2021 | -1.36M |
| March 31, 2021 | -2.897M |
| December 31, 2020 | 0.095M |
| September 30, 2020 | -2.691M |
| June 30, 2020 | -4.846M |
| March 31, 2020 | -2.756M |
| December 31, 2019 | 0.39M |
| September 30, 2019 | -6.048M |
| June 30, 2019 | -3.081M |
| March 31, 2019 | -3.114M |
| December 31, 2018 | -5.144M |
| September 30, 2018 | -12.25M |
| June 30, 2018 | 4.061M |
| March 31, 2018 | -4.061M |
| December 31, 2017 | -4.509M |
| Date | Value |
|---|---|
| September 30, 2017 | -3.727M |
| June 30, 2017 | -3.186M |
| March 31, 2017 | -4.758M |
| December 31, 2016 | -3.781M |
| September 30, 2016 | -5.555M |
| June 30, 2016 | -7.108M |
| March 31, 2016 | -5.431M |
| December 31, 2015 | -12.08M |
| September 30, 2015 | -3.177M |
| June 30, 2015 | -7.221M |
| March 31, 2015 | -5.225M |
| December 31, 2014 | -12.26M |
| September 30, 2014 | -6.381M |
| June 30, 2014 | -4.076M |
| March 31, 2014 | -5.042M |
| December 31, 2013 | -8.499M |
| September 30, 2013 | -42.76M |
| June 30, 2013 | -5.019M |
| March 31, 2013 | -4.91M |
| December 31, 2012 | -6.569M |
| September 30, 2012 | -3.527M |
| June 30, 2012 | 8.48M |
| March 31, 2012 | -8.344M |
| December 31, 2011 | -3.279M |
| September 30, 2011 | -2.402M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-6.048M
Minimum
Sep 2019
27.86M
Maximum
Jun 2023
-0.4657M
Average
-1.715M
Median
Mar 2022
Cash from Investing (Quarterly) Benchmarks
| Avadel Pharmaceuticals PLC | 21.39M |
| Amarin Corp PLC | 28.72M |
| DBV Technologies SA | -2.132M |
| Adaptimmune Therapeutics PLC | -0.358M |
| Akari Therapeutics PLC | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 0.242M |
| Cash from Financing (Quarterly) | -1.763M |
| Free Cash Flow | -14.26M |
| Free Cash Flow Per Share (Quarterly) | -0.0513 |
| Free Cash Flow to Equity (Quarterly) | -1.016M |
| Free Cash Flow to Firm (Quarterly) | 1.076M |
| Free Cash Flow Yield | -101.4% |